CD163 and myeloid sarcoma: Concomitantly, the M2 marker genes ARG1, CD163, and CD206 as well as the gene encoding the anti-inflammatory cytokine IL10 were all increased in monocytes of healthy subjects and MS patients following MP treatment, although the differences were not always statistically significant (Figures 4C–F).